Why Today’s Large Cap Growth is More Precarious than the Nifty Fifty
This paper seeks to discredit the “quality & growth at any price” thesis underpinning many of the market’s leading growth firms. Kailash intends to review and provide evidence of the following:
- The Collision of Arithmetic & Over-Optimism: The valuation of the US market’s largest growth firms has eclipsed the confines of arithmetic reality
- Nothing Nifty About the Fifty: Like Howard Marks, Kailash shares the belief that legendary academic Jeremy Siegel’s view that the 1970’s Nifty Fifty were overvalued by “…a very small margin” is a misleading and dangerous concept
- Buying Things Well, Not Buying Good Things: The view “it pays to worship fundamentals even when all assets are going up in price” is of critical importance when market manias become focused on a select few firms like today
Jeremy Siegel published an article in 1998 stating that the “Nifty Fifty” were “properly valued at the peak” as the stocks performed nearly as well as the S&P500 over the ensuing 25 years. The paper described the Nifty Fifty as “high market capitalization stocks…” that traded at “…50, 80 or even 100 times earnings” representing “the world’s preeminent growth companies.”
This definition is important. Acknowledging there never was an official “Nifty Fifty,” Siegel used a list of names published by Morgan Guaranty Trust. As Siegel stated of the 50 stocks he analyzed: “the 25 stocks with the highest P/E ratios yielded half the subsequent return as the 25 stocks with the lowest P/E ratios.” As evidenced here, the fact that valuation created a 2:1 return advantage within a group of 50 richly valued stocks is, in our view, the most valuable component of his paper. Accordingly, Kailash uses the 25 most expensive stocks within the 50 largest firms in this paper to verify the magnitude of the pricing error driving markets today.
Figure 1 below shows that the market cap of the Largest 25 Growth firms have never in history been as highly valued relative to GDP as they are today.
Kailash has repeatedly used Warren Buffet’s Market Cap to GDP metric to express our rising concern with aggregate market valuations in pieces like This Time is Different as well as Growth vs. Value Part I and Part II. The Fed is suddenly the biggest asset manager in the world with BlackRock in second place. This leaves us wondering if oceans of funds invested in a fundamentally agnostic manner have abetted the surge in the 25 Largest Growth firms.
Kailash’s concern is based on very simple arithmetic. Figure 2 shows that if the 25 Largest Growth stocks generated a compound annual return of 10% over the next decade, their valuation would rise from $12 trillion today to $31 trillion by 2030 (first two rows). If the US economy grew at a compound rate of 3% annually over the same period, GDP would be $26 trillion by 2030.
The math here is blindingly obvious. Buying the 25 most expensive firms within the 50 largest market cap firms today is an arithmetically reckless bet. Already more expensive relative to US GDP than any time in history, if these firms generate 10% annual returns while the US grows well above any forecasted rate, they will be larger than the US economy in very short order.
The concerns raised by Forbes’ Jesse Colombo about the potential for disaster to strike a richly valued market are as valid today as when he penned Disaster in September of 2018. This is a piece well worth reading (link below) considering the challenging arithmetic facing the Largest 25 Growth firms above. At current valuations, Kailash believes that none of these risks need to manifest themselves to facilitate negative outcomes for investors in the 25 Largest Growth firms.
Contact us below to receive the full pdf.
 AAII Journal, October 1998, Valuing Growth Stocks: Revisiting the Nifty Fifty, Jeremy Siegel
 “Buy Stocks” and “Collect Rent” Is Terrible Investing Advice When Followed on Face Value, Tim Denning
 The Stock Market is Currently Facing the Iceberg Illusion
The information, data, analyses and opinions presented herein (a) do not constitute investment advice, (b) are provided solely for informational purposes and therefore are not, individually or collectively, an offer to buy or sell a security, (c) are not warranted to be correct, complete or accurate, and (d) are subject to change without notice. Kailash Capital, LLC and its affiliates (collectively, “Kailash Capital”) shall not be responsible for any trading decisions, damages or other losses resulting from, or related to, the information, data, analyses or opinions or their use. The information herein may not be reproduced or retransmitted in any manner without the prior written consent of Kailash Capital.
Kailash Capital, in preparing the information, data, analyses and opinions presented herein, has obtained data, statistics and information from sources it believes to be reliable. Kailash Capital, however, does not perform an audit or seeks independent verification of any of the data, statistics, and information it receives.
Kailash Capital and its affiliates do not provide tax, legal or accounting advice. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. You should consult your own tax, legal and accounting advisors before engaging in any transaction.